Abstract:Extracellular matrix-degrading matrix metalloproteinase-1 (MMP-1) is one of the interstitial collagenases likely to be involved in tumor invasion and metastasis. MMP-1 may also contribute to tumor initiation and development by altering the cellular microenvironment that facilitates tumor formation. Recent studies have found that overexpression of MMP-1 is associated with the initial stages of cancer development in addition to promoting cellular invasion; however, preexisting oncogenic mutations or chemical carcinogens are required to initiate tumorigenesis as well. There is a single nucleotide polymorphism located in the promoter region of MMP-1 that partially regulates gene expression. The 2G/2G genotype enhances transcriptional activity and may be associated with an increased lung cancer risk. Using a case-control study, we tested the hypotheses that (a) individuals with the 2G/2G genotype may be at an increased risk for lung cancer; and (b) the risk should be greatly elevated in smoking individuals. PCR-RFLP was used to determine the MMP-1 genotypes in 456 lung-cancer cases and 451 frequency-matched controls of Caucasian ethnicity. Overall, there was a significant association between the 2G/2G genotype and lung cancer risk [odds ratio (OR), 1.76; 95% confidence interval (CI), 1.29–2.39]. In current smokers, the lung cancer risk associated with the 2G/2G genotype was significantly elevated (OR, 3 .16; 95% CI, 1.87–5.35). However, this association was less evident in former smokers (OR, 1.23; 95% CI, 0.81–1.87) and absent in never smokers (OR, 1.09; 95% CI, 0.31–3.91). Similarly, this risk was more evident in heavy smokers (OR, 2.55; 95% CI, 1.61–4.03) than in light smokers (OR, 1.40; 95% CI, 0.84–2.32). Interestingly, men were observed to have a 2.15-fold increased lung cancer risk (OR, 2.15; 95% CI, 1.42–3.26) compared with women (OR, 1.34; 95% CI, 0.84–2.15). Furthermore, subjects with 2G/2G genotype developed lung cancer earlier (60.94 0.64 years old) than patients with 1G/1G and 1G/2G genotypes (62.91 0.59 years old; P 0.024). Our data demonstrate that the 2G/2G genotype enhances lung cancer susceptibility especially in current smokers. To our knowledge, these results report the first molecular epidemiological evidence of the MMP-1 promoter polymorphism associated with the development of lung cancer in the presence of continuing carcinogenic exposure.

The Role of 1G/2G Polymorphism in MMP-1 Gene on Invasiveness of Gastric Cancer

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter is Associated with Colorectal Cancer.

Association of Matrix Metalloproteinase‐2 and ‐9 Promoter Polymorphisms with Colorectal Cancer in Chinese

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility 1

Changes of Histology and Expression of Mmp-2 and Nm23-H1 in Primary and Metastatic Gastric Cancer

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility.

Polymorphisms in the MMP1 and MMP3 Promoter and Non-Small Cell Lung Carcinoma in North China.

No Association Between the Polymorphisms in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Promoter Regions and Colorectal Cancer in Chinese

DHPLC analysis of the matrix metalloproteinase-1 promoter 1G/2G polymorphism that can be easily used to screen large population.

Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan

Polymorphisms in the Promoter Regions of Matrix Metalloproteinases 1 and 3 and Cancer Risk: A Meta-Analysis of 50 Case-Control Studies

Correlation Between A Single Nucleotide Polymorphism In The Matrix Metalloproteinase-2 Promoter And Risk Of Lung Cancer

The Association of MMP9 Promoter Rs3918242 Genotype With Gastric Cancer

Relationship of MMP-2mRNA Expression with Clinical Pathological Features and Prognosis in Gastric Cancer

Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer

[Correlation Between Gene Polymorphisms of Wnt Signalling Pathway Related Components and Risk of Gastric Carcinoma: a Case-Control Study].

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness.

Association of Clinicopathological Factors With MMP13 (rs2252070) Gene Polymorphism in Swedish Patients With Colorectal Cancer

Association of Matrix Metalloproteinase-3 -1171(5A>6A) Polymorphism with Cancer Risk: a Meta-Analysis of 41 Studies.

Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.